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The role of reactive oxygen species and autophagy
in saﬁngol-induced cell death
L-U Ling
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Saﬁngol is a sphingolipid with promising anticancer potential, which is currently in phase I clinical trial. Yet, the underlying
mechanisms of its action remain largely unknown. We reported here that saﬁngol-induced primarily accidental necrotic
cell death in MDA-MB-231 and HT-29 cells, as shown by the increase in the percentage of cells stained positive for
7-aminoactinomycin D, collapse of mitochondria membrane potential and depletion of intracellular ATP. Importantly, saﬁngol
treatment produced time- and concentration-dependent reactive oxygen species (ROS) generation. Autophagy was triggered
followingsaﬁngoltreatment,asreﬂectedbytheformationofautophagosomes,acidicvacuoles,increasedlightchain3-IIandAtg
biomarkers expression. Interestingly, scavenging ROS with N-acetyl-L-cysteine could prevent the autophagic features and
reverse saﬁngol-induced necrosis. Our data also suggested that autophagy was a cell repair mechanism, as suppression of
autophagy by 3-methyladenine or baﬁlomycin A1 signiﬁcantly augmented cell death on 2-5lM saﬁngol treatment. In addition,
Bcl-xL and Bax might be involved in the regulation of saﬁngol-induced autophagy. Finally, glucose uptake was shown to be
inhibited by saﬁngol treatment, which was associated with an increase in p-AMPK expression. Taken together, our data
suggested thatROS wasthemediatorofsaﬁngol-inducedcancer celldeath,andautophagy islikelytobeamechanismtriggered
to repair damages from ROS generation on saﬁngol treatment.
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Oxidative stress occurs in cells when an imbalance exists to
favor the production of reactive oxygen species (ROS), such
as superoxide (O2
K ), hydroxyl radical (HO
K) and hydrogen
peroxide (H2O2) over antioxidant defenses.
1 Oxidative stress
has been implicated in a number of human physiological and
pathological processes, including cancer, ischemic injury,
neurodegenerative diseases, chronic inﬂammation, type II
diabetes and arteriosclerosis. ROS is recognized as a central
mediator in deciding the fate of a cell, depending on the extent
of oxidative damage.
2 Under physiological conditions, low
levels of ROS activate various cellular signaling molecules,
such as tyrosine kinase, mitogen-activated protein kinase,
small Ras proteins, nuclear factor kappa B (NF-kB) and
hypoxia-inducible factor a, leading to growth adaptation and
survival.
2 In contrast, excessive production of ROS causes
irreversible damage to lipids, DNA and proteins, thus
provoking cell death through several modes, including
apoptosis and necrosis.
2 Cancer cells with their higher
metabolic rate even at basal conditions would result in high
intracellular ROS concentrations. This in turn makes cancer
cells under increased oxidative stress and more vulnerable to
ROS-mediated insults and cell death.
Apoptosis is the best-described type of programmed cell
death, which is characterized by distinct morphologic
features, such as cell membrane blebbing, reduction of
cellular volume, activation of caspases, chromatin condensa-
tion and nuclear fragmentation.
3 Necrosis, on the other hand,
is less well-characterized and associated with features
including rupture of cell plasma membrane, loss of mitochon-
dria membrane potential (MMP), depletion of adenosine
triphosphate (ATP) levels and overproduction of ROS.
3 For
a long time, necrosis is considered as an accidental form of
cell death. However, accumulating evidence over the last
decade supports a sequence of events that characterize
necrosis, which could involve death receptors and receptor-
interacting protein 1 (RIP1) kinase.
4 Recently, ROS is also
shown to regulate autophagy,
5 a catabolic process, which is
not only involved in energy homeostasis, organelle turnover
and development, but also in cancer cell death.
3 Various
ROS-generating drugs have proven to be effective in cancer
research by causing mitochondria damage and cell death.
Saﬁngol ((2S, 3S)-2-amino-1,3-octadecanediol) is a satu-
rated analog of sphingosine that belongs to the family of
sphingolipids.
6–8 Saﬁngol is currently under a phase I clinical
trialincombinationwithcisplatinforthetreatmentofadvanced
solid tumors.
9 In addition, several in vitro and in vivo studies
demonstrated that saﬁngol augmented the efﬁcacy of
other chemotherapeutic agents, including fenretinide, 1-b-D-
arabinofuranosylcytosine, cisplatin, vinblastine, irinotecan
and mitomycin-C in a variety of tumor cell lines.
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potential of saﬁngol, the underlying mechanism of saﬁngol
remains largely unknown.
The cytotoxic effect of saﬁngol was previously shown to be
attributed to the inhibition of sphingosine kinase, thus
preventing the formation of sphingosine-1-phosphate, which
is involved in cell proliferation, invasion and angiogenesis.
6 In
addition, saﬁngol was also reported to inhibit protein kinase C
(PKC) by displacing phorbol dibutyrate from PKC regulatory
domain.
8,16 However, we
15 and others
10,17 have shown that
PKC inhibition may not be the primary mechanism by which
saﬁngol induces cell death, particularly at clinically achievable
concentrations (p10mM). Recent investigations shed new
light that saﬁngol could induce cell death associated with
autophagic features.
17,18 Furthermore, modulations of Bcl-2
family proteins, such as Bim and Bcl-xL
19 as well as
endonuclease G from mitochondria were also implicated in
saﬁngol-induced cell death at 10–50mM saﬁngol.
19,20 At
present, there are two main questions remain unanswered.
First, the role of ROS in saﬁngol-treated cancer cells is yet to
be explored. Several reports have demonstrated that
saﬁngol induced ROS production in fungi and plant cells,
21,22
yet no studies have been performed in human cancer cells.
Moreover, bioactive lipids, such as ceramide were reported to
induce ROS production in lymphoid cells.
23 Second, the role
and regulation of autophagy in saﬁngol-treated cells remain
elusive, as modulation or inhibition of saﬁngol-induced
autophagy has not been correlated with an increase or
decrease in cell death. A recent breakthrough revealed that
Bcl-2 family proteins including Bcl-2, Bcl-xL and Bax regulate
autophagy,
24,25 despite the well-established role of these
proteins in apoptosis. Increasing evidence shows a link
between ROS and autophagy, in which ROS generation
could trigger autophagy.
5 Therefore, in this study, we sought
to elucidate the role of ROS and autophagy in determining the
fate of saﬁngol-treated cells. Here, we identify that ROS has a
critical role in causing cell death by necrosis in saﬁngol-
treated cells, and autophagy is induced as a cell repair
mechanism to counteract the damaging effect caused
by ROS.
Results
Saﬁngol induced necrosis in MDA-MB-231 and HT-29
cells. Previously, saﬁngol was shown to induce cell death in
a caspase-independent manner,
17,19,20,26 and we could
obtain similar results in MDA-MB-231 and HT-29 cells with
speciﬁc inhibitors to caspases 8 and 9 and pan-caspase
inhibitor (data not shown). In order to characterize the
mechanism by which saﬁngol exerts its cell killing effect, we
performed ﬂow cytometric analysis after staining the cells
with annexin V-FITC/7-aminoactinomycin D (7AAD).
Paraformaldehyde 2% was included as a positive control
for inducing necrosis in cells. No signiﬁcant increase in the
percentage of cells stained positive for annexin V-FITC was
observed in MDA-MB-231 and HT-29 cells after a 48-h
exposure to saﬁngol (Figure 1a). In contrast, concentration-
dependent increase in the percentage of cells stained
positive for 7AAD was observed (Figure 1a), indicating a
loss of cell membrane integrity that is suggestive of necrotic
cell death. A shorter treatment time of 24h with 10mM
saﬁngol yielded similar results (Figure 1 inset), indicating
that plasma membrane permeabilization, as reﬂected by
7AAD positivity, occurred early on as opposed to delayed
occurrence that is associated with late-stage apoptosis. As
the loss of MMP and depletion of ATP have been described
as the hallmarks of necrosis,
3,4 we further performed
measurements on these two biochemical events.
Remarkable loss of MMP in HT-29 cells was observed after
a 48-h exposure to 10mM saﬁngol (Figure 1b). Signiﬁcant
depletion of cellular ATP was also observed in both cell lines
with 10mM saﬁngol (Figure 1c). Taken together, these data
suggest that necrosis, rather than apoptosis, is the main
mode through which cancer cell death occurred on saﬁngol
treatment. We further examined whether the execution of
necrotic cell death is a programmed event that involves RIP1
kinase. Cells were exposed to saﬁngol with or without
necrostatin-1, a small molecule inhibitor of RIP1 kinase.
27
Our results indicated that necrostatin-1 did not prevent
saﬁngol-induced cell death (Figure 1d), thus suggesting an
accidental form of necrotic cell death.
Exposure to saﬁngol triggered ROS generation. In light
of previous ﬁndings that saﬁngol could induce ROS
generation in fungi and plant cells,
21,22 we were interested
to probe if ROS would be generated in cancer cells on
saﬁngol treatment. MDA-MB-231 and HT-29 cells were
loaded with the ROS probe, 20,70-dichlorodihydroﬂuorescein
diacetate (H2DCFDA), and H2O2 was included as a positive
control. As shown in Figure 2, saﬁngol-induced ROS
generation in a time- and concentration-dependent manner,
as reﬂected by the increase in ﬂuorescence intensity. The
highest amount of ROS was generated after 8h of exposure
to 10mM saﬁngol, with B11- and 7-fold increases over
untreated control in MDA-MB-231 and HT-29 cells,
respectively (Figures 2a and b).
ROS triggered induction of autophagy in MDA-MB-231
and HT-29 cells. On the basis of the results presented in
Figure 2, we postulated that autophagy would be triggered in
the cancer cells on saﬁngol treatment, as ROS could induce
cellular damages.
2 As demonstrated through the
ultrastructural morphology using transmission electron
microscopy, saﬁngol-treated MDA-MB-231 and HT-29 cells
displayed characteristic autophagosomes, as well as
cytoplasmic vacuoles (Figure 3a). Concentration-dependent
formation of acidic vesicular organelles (AVOs) could be
observed in saﬁngol-treated cells when stained with the
lysosomo-tropic agent, acridine orange,
28 and formation of
AVO was markedly suppressed in both cell lines in the
presence of 1mM 3-methyladenine (3-MA), the most
commonly used autophagy inhibitor
29 (Figure 3b). Induction
of autophagy is further supported by the conversion of light
chain 3 (LC3)-I to LC3-II in a concentration- and time-
dependent manner on saﬁngol treatment in the two cell lines
(Figures 3c and d). A trend of increasing expression of the
Atg proteins (Atg 5, 7 and 12) in MDA-MB-231 and HT-29
cells over the course of 48h was also observed on saﬁngol
treatment (Figure 3d). Importantly, in the presence of the
ROS and autophagy in saﬁngol-treated cells
L-U Ling et al
2
Cell Death and DiseaseMDA-MB-231
1.18±
0.15%
3.71±
0.48%
8.51±
0.70%
68.4±
1.87%
1.27±
0.38%
0.21±
0.11%
4.69±
1.54%
0.59±
0.03%
0.81±
0.18%
0.48±
0.14%
Annexin V-FITC
1.13±
0.28%
0.24±
0.06%
control 10 M 2 M5   M
7
A
A
D
1.54±
0.23%
0.46±
0.23%
0.20±
0.08%
4.74±
0.92%
0.87±
0.29%
0.36±
0.17%
7.56±
1.67%
1.03±
0.41%
0.48±
0.20%
86.9±
0.63%
2.62±
0.90%
0.01±
0.01%
97.8±
0.45%
94.0±
0.56%
90.9±
1.28%
10.4±
1.29%
64.8±
1.40%
4.39±
2.23%
0.16±
0.13%
30.7±
1.54%
paraformaldehyde
97.5±
0.29%
95.5±
0.41%
85.7±
1.35%
30.1±
1.57%
73.3±
8.32%
2.06±
0.38%
0.09±
0.04%
24.6±
7.91%
HT-29
0
20
40
60
80
100
MDA-MB-231
- Necrostatin-1
+ Necrostatin-1
Safingol concentration (M)
V
i
a
b
i
l
i
t
y
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
HT-29
- Necrostatin-1
+ Necrostatin-1
Safingol concentration (M)
0
20
40
60
80
100
V
i
a
b
i
l
i
t
y
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
7.5×10-4
2.5×10-4
5.0×10-4
0.0×10-0
1.0×10-3
1.3×10-3
1.5×10-3
1.8×10-3
A
T
P
 
(
M
)
0
MDA-MB-231
*
Safingol concentration (M)
2.5×10
-4
5.0×10
-4
7.5×10
-4
1.0×10
-3
0.0×10
-0
A
T
P
 
(
M
)
*
HT-29
Safingol concentration (M)
Control 8 24 48
HT-29
Green
R
e
d 94.1 ±
0.7%
77.1*
±1.0%
34.1*
±1.8%
10.0*
±1.0%
39.4±
1.77%
5.35±
0.39%
0.19±
0.04%
55.1±
2.21%
21.1±
1.52%
3.53±
0.11%
0.50±
0.01%
74.9±
1.42%
MDA-MB-231
HT-29
24 h 10 M Saf
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
103
102
101
100
103 102 101 100 103 102 101 100 103 102 101 100 103 102 101 100
103
102
101
100
103
102
101
100
103
102
101
100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
104
103
102
101
100
104 103 102 101 100
h
21 0 5
21 0 52 1 0 5
02 1 0 5
Figure 1 Cell death mechanism induced by saﬁngol treatment in MDA-MB-231 and HT-29 cells. (a) Flow cytometric analysis of MDA-MB-231 and HT-29 cells
after2, 5 and10mM saﬁngol treatmentfor 48h. In all, 2% paraformaldehydewas usedas a positivecontrol to induce necrosis.Cells were harvestedand stained with annexin
V-FITC/7AAD before analyzed by ﬂow cytometry. Results from treatment with 10mM saﬁngol for 24h in the two cell lines are shown in the inset. Each reported value
represents the mean±S.E.M. from three independent experiments. (b) Effect of saﬁngol on MMP in HT-29 cells. Cells were treated with 10mM saﬁngol for 8, 24 and 48h,
stained with JC-1 and subjected to ﬂow cytometry. Representative dot plots from three independent experiments were shown, and numerical values represent
means±S.E.M. (n¼3). (c) Effect of saﬁngol on intracellular ATP. Cells were treated with 2, 5 and 10mM saﬁngol for 48h before measurement of ATP by a luminometric
assay. Results shown are means±S.E.M. from three independent experiments. (d) Effect of necrostatin-1 on the viability of saﬁngol-treated cells. Cells were treated with
saﬁngol±100mM necrostatin-1 for 48h. Viability was assessed using MTT assay. Results shown are means±S.E.M. from three independent experiments. *Po0.05,
compared with untreated control
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Cell Death and DiseaseROS scavenger, N-acetyl-L-cysteine (NAC), marked
reduction in the formation of AVO and in the conversion of
LC3-I to LC3-II could be demonstrated in MDA-MB-231 and
HT-29 cells (Figures 4a and b). Taken together, our results
have demonstrated that saﬁngol is capable of inducing
autophagy, which are in line with two recent reports,
17,18 and
that autophagy is induced as a result of ROS generation on
saﬁngol treatment.
The role of autophagy and ROS in saﬁngol-treated
MDA-MB-231 and HT-29 cells. Increased autophagic activity
has been suggested to associate with cell death despite a lack
of causative relationship of these two events.
3 On the other
hand, cell death could be accelerated when autophagy is
suppressed, suggesting a pro-survival role of autophagy.
3 To
assess the role of autophagy in saﬁngol-induced cancer cell
death, we have used two different pharmacological inhibitors of
autophagy, 3-MA and baﬁlomycin A1 (BA1), which act at
different points of the autophagic pathway.
29,30 Viability was
485% of control when the cancer cells were exposed to 3-MA
or BA1 alone. Suppression of autophagy by the inhibitors did
not block cell death brought about by 2 or 5mM saﬁngol
(Figure 5a). On the contrary, signiﬁcant augmentation in cell
death was observed on autophagy suppression. At the highest
concentration of saﬁngol tested (10mM), the presence of 3-MA
or BA1 did not impart any signiﬁcant effect on cell viability
(Figure 5a). These ﬁndings suggest that low concentrations
(2–5mM) of saﬁngol induced low levels of ROS and damage
whereby the autophagic pathway could possibly degrade the
damaged cellular components. In contrast, it is possible that a
high concentration of saﬁngol-induced signiﬁcant levels of
ROS and damage that is beyond repair. Further studies
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Figure 2 Detection of ROS by ﬂuorescence intensity measurement using a microplate reader and ﬂuorescence microscope. (a) Cells were treated with 2mM (K), 5mM
(.), 10mM (~) saﬁngol and 200mM H2O2 (’) for the indicated time before incubation with 5mM H2DCFDA. Fluorescence intensity was measured. In parallel, cell viability
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#Po0.05, compared with untreated control). (b) Cells were
treated with 2, 5 and 10mM saﬁngol and H2O2 for 8h. After incubation with 5mM H2DCFDA, cells were washed and examined by ﬂuorescence microscope. Representative
images of cells from three independent experiments were shown. Bar¼100mm
Figure 3 Induction of autophagy in MDA-MB-231 and HT-29 cells. (a) Ultrastructural features of saﬁngol-treated cells. MDA-MB-231 cells were treated with 5mM saﬁngol
whileHT-29 cells weretreatedwith 10mM saﬁngol for 24h. Cells wereharvested, ﬁxedand observedunder transmission electronmicroscopy.Representativeimages of cells
from three independent experiments with different magniﬁcation and scale bars were shown. (a) Control; (b–d) saﬁngol-treated cells. N indicates nucleus; M indicates
mitochondria; arrowindicates double membranestructure. (b) Detection of AVO in saﬁngol-treatedcells. Cells were treated with saﬁngol±1m M 3-MA for 24h before stained
with 1mg/ml acridine orange for 15min. Cells were examined by ﬂuorescence microscopy. Representative images of cells from three independent experiments were shown.
Bar¼50mm. (c) Concentration-dependent upregulation of LC3-II after saﬁngol treatment for 48h. (d) Time-dependent upregulation of LC3-II, Atg 7, Atg 5 and Atg 12
expression after 10mM saﬁngol treatment. Protein lysates were collected and assayed by western blotting. b-Actin was used as the loading control. All blots shown are
representativeofthreeindependentexperiments.Lowerpanelsshowthedensitometricanalysiswherethebandintensitiesoftheproteinsunderinvestigationwerenormalized
to that of b-actin in the respective cell lines. Results shown are means±S.E.M. from three independent experiments. (*Po0.05, compared with t¼0h)
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Cell Death and Diseasecorrelating the amount of oxidized cellular proteins with the
induction of autophagy would provide further insights into the
catabolic role of autophagy on saﬁngol treatment.
To further substantiate the role ROS has in saﬁngol-
induced cancer cell death, we examined the viability of MDA-
MB-231 and HT-29 cells in the presence and absence of the
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Cell Death and DiseaseROS scavenger, NAC. Indeed, on removal of ROS by NAC,
the percentage of saﬁngol-treated cells stained positive
for 7AAD was signiﬁcantly reduced from 86.9 to 14.6% for
MDA-MB-231 and from 68.4 to 42.4% for HT-29 (Figure 5b).
Taken together, our data indicate that ROS have an important
role in mediating saﬁngol-induced autophagy and necrotic
cell death.
Bcl-xL and Bax regulates saﬁngol-induced auto-
phagy. On the basis of the recent ﬁndings that Bcl-2
homologues regulate autophagy by binding directly to
beclin-1, which is an autophagy-inducing protein that
contains a Bcl-2 homology 3 domain,
24,31 we examined the
involvement of beclin-1, Bcl-xL and Bax in saﬁngol-induced
autophagy. Speciﬁcally, the ratios of beclin-1/Bcl-xL
expression were determined instead of the changes in
expression levels of the individual proteins, as the ratio of
beclin-1/Bcl-xL expression is important to the regulation of
autophagy – a mechanism that is analogous to the regulation
of apoptosis by the Bcl-2 protein family, which is based on
the ratio of pro-apoptotic/anti-apoptotic proteins. From
Figure 6a, signiﬁcant increases in the ratio of beclin-1/Bcl-
xL were observed at 24 and 48h for MDA-MB-231 cells and
at 48h for HT-29 cells. A concomitant increase in Bax
expression was also observed.
Stemming from the results in Figure 6a, we hypothesized
that the use of gossypol, which is an inhibitor of Bcl-xL could
possibly suppress the Bcl-xL-mediated inhibitory effect on
autophagy and thereby promoting the occurrence of autop-
hagy. Results from Figure 6b are consistent with this notion,
whereby an increase in AVO formation could be observed in
the presence of gossypol when the cells were treated with
saﬁngol. In light of the results presented in Figures 2-5,
autophagy is likely to be a catabolic process triggered by ROS
overproduction on saﬁngol treatment, we thus further
hypothesized that inhibition of Bcl-xL by gossypol would have
less suppressive effect on autophagy, which in turn would
possibly result in more catabolism of ROS-damaged cellular
components and promotion of cell survival. Consistent with
this hypothesis, it was found that gossypol-treated cells
became less sensitive to saﬁngol treatment, as reﬂected by
signiﬁcant increases in IC50 values (Figure 6c). However,
the regulatory mechanism of autophagy is complex that
involvesmultiplesignalingpathways,anditispossiblethatthe
use of gossypol could affect other molecular signals that
contribute to the regulation of autophagy in addition to
modulation of Bcl-xL.
Saﬁngol reduced glucose uptake. Our results thus far
suggest that ROS generation mediates saﬁngol-induced
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Figure 4 ROStriggerautophagyinductioninMDA-MB-231and HT-29cells.(a) DetectionofAVO insaﬁngol-treatedcellsinthe presence of NAC.Cells weretreatedwith
saﬁngol±10mM NAC for 24h before stained with 1mg/ml acridine orange for 15min. Cells were examined by ﬂuorescence microscopy. Representative images of cells from
three independent experiments were shown. Bar¼50mm. (b) Downregulation of LC3-II in cells in the presence of NAC. Cells were treated with saﬁngol±10mM NAC for
48h. Protein lysates were assayed by western blotting and b-actin was used as the loading control. All blots shown are representative of three independent experiments
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Cell Death and Diseasecancer cell death. It is therefore of interest to investigate how
saﬁngol induced ROS generation in these cells. Previously,
sphingolipids have been shown to inhibit glucose uptake,
32,33
which could in turn induce oxidative stress.
34 These reports
provided the basis for us to hypothesize that saﬁngol, a
synthetic sphingolipid, might be able to inhibit glucose
uptake. Using a ﬂuorescent derivative of glucose,
2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose
(2-NBDG), the uptake was probed in MDA-MB-231 and
HT-29 cells. Our results showed that 10mM saﬁngol
signiﬁcantly inhibited 2-NBDG uptake in both cell lines as
early as 2h (Figure 7a), preceding the generation of ROS
(Figure 2).
Considering the ﬁnding that AMP-activated protein kinase
(AMPK) and mammalian target of rapamycin (mTOR) are
critical energy sensors that also have a role in autophagy
regulation,
35 the effect of saﬁngol on the phosphorylation of
AMPK and mTOR was examined. As shown in Figure 7b,
10mM saﬁngol caused a rapid and signiﬁcant increase in
AMPK phosphorylation at 2h in both cell lines, which is in line
with the observation that saﬁngol inhibited glucose uptake
(Figure 7a). The expression of phosphorylated mTOR was
initially increased in saﬁngol-treated MDA-MB-231 and HT-29
cells, which was subsequently reduced at 24 and 48h
(Figure 7b). The initial increase in phosphorylated mTOR is
intriguing and warrantsfurther investigation, whichcouldshed
new light on the possible involvement of other signals that
regulate the expression of phosphorylated mTOR during
autophagy induction in addition to AMPK.
Discussion
To our knowledge, this is the ﬁrst report showing that ROS
have a key role in saﬁngol-treated human cancer cell lines,
MDA-MB-231 and HT-29. Interestingly, such ROS production
could also trigger autophagy, which appeared to be a repair
mechanism. We have also shown that glucose uptake is
inhibited by saﬁngol, which is an event preceding ROS
generation. On the basis of these ﬁndings, we propose a
model depicting the possible mechanism of action of saﬁngol
in MDA-MB-231 and HT-29 cells (Figure 8).
Regardless of how and where ROS are generated, a rise in
ROS levels has two potential consequences: damage to
cellular components and triggering various signaling path-
ways.
1 Here, we show that accumulation of ROS is essential
for saﬁngol-induced cell death as such death can be largely
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Cell Death and Diseaseprevented by NAC. However, in Aspergillus nidulans, Cheng
et al.
21 reported that the fungicidal activity of saﬁngol does not
require ROS, despite a rapid accumulation of ROS was
observed. Such discrepancy is likely due to the difference in
cancer cell response compared with that of fungi. In addition,
we found that ROS generation is a relatively early event,
suggesting that ROS could be the mediator leading to the loss
of MMP, possibly by triggering the opening of the mitochon-
dria permeability transition pore that subsequently leads to
celldeath.Ourresultsalsodemonstratedthatsaﬁngol-treated
cells undergo accidental necrotic cell death, as reﬂected by
the caspase-independent cell death, rupture of plasma
membrane integrity, loss of MMP and depletion of ATP, but
not the involvement of RIP1 kinase. By targeting a non-
apoptotic cell death pathway, saﬁngol might provide an
alternative strategy for developing combination therapies, in
particular to eliminate cells, which are resistant to apoptotic
cell death.
In line with two previous studies,
17,18 our results have
demonstrated that saﬁngol induced autophagy, possibly
being regulated by Bcl-2 family proteins. The downregulation
of Bcl-xL and upregulation of Bax observed in our study is
consistent with the ﬁnding that arsenic trioxide induced
autophagy in U118 human glioma cells in the absence of
apoptosis, despite being regulated by Bcl-2 family proteins.
36
Parallel with this, studies have illustrated the binding of Bcl-xL
and Bcl-2 to beclin-1, thus preventing autophagy.
24 On the
other hand, Bax activation has been shown to induce
autophagy, which is Atg 5-, Atg7- and Atg10-dependent.
25
Although saﬁngol-induced autophagy has been clearly
demonstrated, it is yet to unveil whether such autophagy
directly contributes to death or is a failed effort to preserve cell
viability. Our results suggest the latter, where autophagy
functions possibly as a mechanism to remove damaged
organelles and proteins in response to saﬁngol-induced
oxidative stress. In addition to supporting the current knowl-
edge that ROS regulates autophagy,
5 our data are also in line
with ﬁndings that demonstrated the protective role of
autophagy induced by sphingolipids in cell death, especially
during nutrient starvation.
37
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Cell Death and DiseaseConsistent with our study, short-chain fatty acids were
shown to induce ROS production, which led to AMPK
activation and consequential mTOR inhibition.
38 Our results
offer an explanation that glucose uptake inhibition by saﬁngol
could be one of the factors leading to an increase in AMPK
phosphorylation in parallel with ROS generation. Under
metabolic stresses, such as glucose deprivation, AMPK is
activated to increase catabolism, either by direct phosphor-
ylation of metabolic enzymes or regulation of transcription.
39
Similarly, glucose deprivation was shown to initiate oxidative
stress and increase mitochondria production of ROS, as
demonstrated in lung cancer cells A549, brain cells, retina
cells and adrenal cells.
34 Although several in vivo studies
supported the upstream role of ROS in activating AMPK,
40
this remains to be determined in saﬁngol-treated cells. AMPK
is not only known as an energy sensor, but also reported to
have a role in inducing autophagy through the suppression of
mTOR.
35 However, in our study, the initial increase in
phosphorylated mTOR is intriguing that warrants further
investigation, which could yield new insights into the signals
in the regulation of phosphorylated mTOR expression during
autophagyinduction.Ofnote,ithasbeenshownthatthe PI3k/
Akt/mTOR pathway was involved in regulating saﬁngol-
induced autophagy.
17 Thus, the PI3k/Akt pathway could be
involved in regulating p-mTOR expression in addition to
AMPK. The direct effect of AMPK and mTOR on saﬁngol-
induced autophagy could be further studied with pharmaco-
logical activators and inhibitors of AMPK and mTOR so as to
tease out the contribution of AMPK-mTOR signaling in
saﬁngol-induced autophagy and necrosis.
In summary, our studies provide experimental evidence that
ROS have a key role in mediating the cytotoxicity of saﬁngol in
cancer cells. It is worthwhile to note that depending on the
magnitude and the duration of exposure, ROS can elicit
differentresponses.Saﬁngolat2and5mMresultedinlowlevels
of ROS production, and autophagy was possibly induced to
remove oxidatively damaged organelles. However, at 10mM
saﬁngol treatment, high levels of ROS were produced and
possiblyexceededthe cells’ repair capacityand thus leading to
cell death by necrosis. Together, these data suggest that
saﬁngol may be an attractive agent to combine with apoptotic-
and ROS-generating anticancer drugs at appropriate concen-
trationstotreatpotentialdrug-resistantcancers.Itisanticipated
thatsuchcombinationsofdrugsmayshowsynergisticeffectby
executing different modes of cell death.
Materials and Methods
Reagents. Saﬁngol was purchased from Sigma-Aldrich (St. Louis, MO, USA)
and dissolved in ethanol. Stock solutions of 2mg/ml were stored at  201C and
freshly diluted with medium to the appropriate concentrations before use in
experiments. All other chemicals used in the study were purchased from Sigma-
Aldrich unless otherwise stated.
Cell cultures. Two human cancer cell lines, MDA-MB-231 and HT-29, were
purchased from American Type Culture Collection (Manassas, VA, USA). Stock
cultures of both cancer cell lines were maintained as monolayer in 75-cm
2 tissue
culture ﬂasks (Iwaki, Japan). MDA-MB-231 cells were cultured in Roswell Park
Memorial Institute 1640 (RPMI-1640) medium while HT-29 in Iscove’s modiﬁed
Dulbecco’s medium. All media were supplemented with 10% v/v fetal bovine serum
(HyClone Laboratories, Logan, UT, USA), 0.3g/l L-glutamine, 100U/ml penicillin
and100mg/mlstreptomycin.Thecelllinesweremaintainedinahumidiﬁed,5%CO2
incubator at 371C and sub-cultured twice weekly using 0.25% v/v trypsin/EDTA
(GIBCO, Grand Island, NY, USA). All experiments were performed using cells in
exponential growth phase from passage 5 to 20 post-thawing from frozen stock.
Cell viability assay. Viability of the cancer cells following drug treatment was
determined using the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) assay. In brief, cells were plated at 5000 per well in
96-well plates and allowed to adhere overnight before exposure to
saﬁngol±inhibitors/agents. The plates were then incubated for speciﬁed period
at 371C. At the end of the incubation, 50ml MTT (1mg/ml in media) was added to
cells and incubated for 4h. Subsequently, the MTT-containing medium was
removed, and the purple formazan precipitate was solubilized in DMSO with
shaking. Absorbance reading (l¼570nm) was measured using a microtiter plate
reader (Tecan, Inﬁnite 200 PRO, Tecan Group Ltd, Mannedorf, Switzerland). All
assays were done at least three times unless otherwise stated.
Cancer cell viability was calculated based on the absorbance readings using
the following equation: viability¼((Abstest–Absblank)/(Absvehicle control–Absblank))
 100%, where Abstest, Absblank, Absvehicle control represent the absorbance
readings from the drug-treated wells, the medium only wells and the vehicle
control wells, respectively.
Flow cytometry with annexin V-FITC/7AAD staining. In brief,
1.5 10
6 cells were seeded and treated with various concentrations of
saﬁngol±10mM NAC in MDA-MB-231 and 2.5mM NAC in HT-29 cells for 48h.
2% paraformaldehyde was used as a positive control for inducing cell death with
necrotic features. After drug exposure, cells were harvested, washed with ice-cold
phosphate-buffered saline (PBS), and stained with annexin V-FITC/7AAD kit
(Beckman Coulter, Villepinte, France) for 15min in dark. In all, 450ml of binding
buffer were added to terminate the reaction. The samples were kept on ice before
subjected to ﬂow cytometric analysis. Stained samples were analyzed on the Dako
ﬂow cytometer (Dako Cytomation Cyan LX, Dako Corp., Carpinteria, CA, USA) and
10000 events were collected. Data were plotted with Summit V4.3 Build 2445
software (Dako Colorado Inc., Fort Collins, CO, USA).
MMP measurement. In all, 1.5 10
6 cells were seeded in T-75 ﬂasks and
treated for 8, 24 and 48h with 10mM saﬁngol. Then, 1 10
5 cells were harvested
and incubated with 100ml 5,50,6,60 tetrachloro-1,10,3,30-tetraethylbenzimidazolyl-
carbocyanine iodide (JC-1) at a ﬁnal concentration of 1mg/ml for 30min at 371C.
In healthy cells, JC-1 stains the mitochondria red whereas in cells with collapsed
MMP, JC-1 remains in the cytoplasm and emits green ﬂuorescence. After staining,
cellswerewashedtwicewithice-coldPBSandsubjectedtoﬂowcytometryanalyses
using Dako ﬂow cytometer model CyAn ADP, and 10000 events were collected.
Data were plotted with Summit V4.3 Build 2445 software.
ATP measurement. In total, 10
5 cells per well were plated in black 96-well
plates and allowed to adhere for 24h. Following 48-h treatment with 2, 5 and 10mM
saﬁngol, ATP levels were measured using the ATP bioluminescence assay kit HSII
(RocheDiagnostics,Indianapolis,IN,USA)accordingtothemanufacturer’sinstruction.
ROS measurement. ROS measurement was performed using H2DCFDA
according to the manufacturer’s instructions. In brief, each 96-well plates was
seeded with 2 10
4 cells per well and allowed to adhere overnight. In all, 2, 5 and
10mM saﬁngol was added for the indicated period. H2O2 was used as a positive
control. Following the drug treatment, media was removed and cells were loaded
with 5mM H2DCFDA diluted in clear media for 30min at 371C. Cells were washed
three times with clear media and ﬂuorescence intensity (excitation¼485nm;
emission¼530nm) was measured using a microtiter plate reader (Tecan, Inﬁnite
M2000). Morphology of cells was photographed using Nikon ECLIPSE TE2000-U
(Nikon Instruments Inc., Melville, NY, USA) microscope. Finally, 100ml of premixed
WST-1 cell proliferation reagent (Clontech Laboratories Inc., Mountain View, CA,
USA)wasaddedtodeterminethecellviability.Abswasmeasuredatl¼440nmin
a microplate reader (Tecan, Inﬁnite 2000). Folds increased in ROS production was
calculated using the following equation: (Ftest–Fblank)/(Fcontrol–Fblank), where Ftest,
Fblank, Fcontrol represent the ﬂuorescence readings from the drug-treated wells, the
unstained cells and the stained control wells, respectively.
Electronmicroscopy. Brieﬂy,cellsweretreatedwithsaﬁngolfor24and48h,
harvestedbytrypsinization,washedtwicewithPBSandpre-ﬁxedwithice-cold2.5%v/v
glutaraldehyde and 2% v/v paraformaldehyde in buffer for 3h. After washing three
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Cell Death and Diseasetimes with PBS, cells were post-ﬁxed in 1% osmium tetroxide in dark for 2h.
A series of graded dehydration was carried out, followed by embedding of cells in
Spurr’s resin. In all, 90nm thin sections were cut, stained with Hiraoka staining kit
(Polyscience Inc., Warrington, PA, USA) and viewed with PHILIPS CM10 (Phillips
Electronics, Mahway, NJ, USA) transmission electron microscope.
Acridine orange staining. Staining of cells with acridine orange was
performed according to published procedures.
28 In brief, acridine orange at a ﬁnal
concentration of 1mg/ml was added to treated-cells for a period of 20min at 371C.
Then, cells were washed twice with PBS. Images of cells were obtained using
Olympus FluoView FV300 (Olympus Inc., Melville, NY, USA) confocal microscope.
Westernblotting. Cellswereexposedsaﬁngolforthespeciﬁedconcentrations
andduration.Insomeexperiments,cellsweretreatedinthepresenceofNAC.After
drug treatment, cells were washed with ice-cold PBS and lysed in ice-cold cell lysis
buffer (20mM Tris pH 7.5, 150mM NaCl, 10mM EDTA, 1% w/v NP-40, 20mM
sodium ﬂuoride, 5mM sodium pyrophosphate, 1mM sodium vanadate, 10% v/v
glycerol, 1  protease inhibitor cocktail) just before use. Protein concentration was
determined using the Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, Hercules,
CA, USA). Proteins were separated by electrophoresis carried out on 1.5-mm thick,
6to12%sodiumdodecylsulfate-polyacrylamidegelsusingBio-Rad’sPowerpacHC
Apparatus (Bio-Rad Laboratories, Singapore) and electroblotted onto nitrocellulose
membranes in ice-cold transfer buffer (39mM glycine, 48mM Tris base, 20% v/v
methanol). The membranes were subsequently blocked with 5% w/v bovine serum
albumin (BSA; Sigma-Aldrich) in Tris-buffered saline with 0.1% v/v Tween 20
(TBS/T) for 2h. The membranes were then probed with primary antibodies
overnight at 41C. Primary rabbit polyclonal LC3-II, beclin-1, Bcl-xL, Bax, p-AMPKa
(Thr 172) and p-mTOR (Ser2448) antibodies were purchased from Cell Signaling
Technology, Inc. (Danvers, MA, USA) and diluted with TBS/T in 1:1000 ratio
containing 5% w/v BSA. Membranes were probed with horseradish peroxidase-
conjugated goat anti-rabbit antibody (Pierce Biotechnology, Rockford, IL, USA) for
another hour, followed by detection with chemi-luminescence Supersignal West
Dura Extended Duration Substrate (Pierce Biotechnology, Rockford, IL, USA).
b-Actin was included as the loading control. The intensities of the individual bands
were determined by densitometry (Image J 1.43u, National Institutes of Health,
Bethesda, MD, USA).
Glucose uptake assay. Cells were plated at 2 10
4 per well and allowed to
adhere overnight. On the following day, cell culture medium was removed and
replaced by glucose-free medium for 24h. Then, saﬁngol at 10mM was added to
cells for the indicated time. At the end of saﬁngol treatment, 0.3mM of 2-NBDG
(Invitrogen, Eugene, OR, USA) diluted in Hanks-buffered salt solution (HBSS) was
addedinto each wellfor 30min at 371C. The2-NBDGuptakereaction was stopped
by removing the medium and washing the cells twice with HBSS. Images of cells
were obtained using Olympus FluoView FV300 confocal microscope.
Statistical analysis. All data values were reported as mean±S.E.M.
Statistical differences were determined using the Student’s t-test or one-way
analysis of variance with Dunnett’s test used for post hoc multiple comparisons.
P-values of o0.05 were considered to be statistically signiﬁcant.
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